Orphalan
An AI Business Lead/Integrator helps organizations identify and realize AI opportunities by bridging business and technology, translating challenges into AI solutions, and ensuring value creation through digital transformation.
Orphalan SA is a specialty biopharmaceutical company focused on innovation for orphan (rare) diseases. The company identifies, develops and commercialises therapies for underserved patient populations, working across clinical development, regulatory strategy and market access. Orphalan collaborates with clinicians, patient groups and commercial partners to bring treatments to patients globally and improve long‑term outcomes.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Orphalan.
Orphalan didn’t post a salary, so this is our estimate from similar listings.